We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST)

This study is currently recruiting participants.
Verified October 2017 by University Hospital, Brest
Sponsor:
ClinicalTrials.gov Identifier:
NCT01848639
First Posted: May 7, 2013
Last Update Posted: November 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
University Hospital, Brest
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2024
  Estimated Primary Completion Date: June 2023 (Final data collection date for primary outcome measure)